glp 1 hospitalization GLP-1s lower death risk in adults with type 2 diabetes, cancer GLP-1 receptor agonists, including semaglutide

Figure 1: Landscape of GLP-1 coverage in Medicaid for weight loss indication "Recent change" is relative to KFFs August 2024 report

The February 20, 2026 FDA action against 30 telehealth companies reshaped the landscape

Patient Information Leaflet

Kobayati A, Haidar A, Tsoukas MA (2022) Glucagon-like peptide-1 receptor agonists as adjunctive treatment for type 1 diabetes: renewed opportunities through tailored approaches

If you are considering GLP-1 Injections or want more information, contact us today at 337-534-4410

All these challenges may be partially mitigated by an evidence-based, structured lifestyle program, particularly around food, when prescribing GLP-1s for obesity